Consistent with the results of immune infiltration analyses, responders (CBP_low) had a higher rate of anti-tumor immune subsets, such as elevated M1/M2 macrophage ratio (Figure 8D), increased CD8+ T cells (Figure 8E) and CD4+ T cells (Figure 8F). The gene discussed is CD8A; the disease is neoplasm.